The authors' reply

Gut

Volumn 61, Issue 1, 2012, Pages 167-

  Pironi, Loris ^a   Forbes, Alastair ^b   Van Gossum, André ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PARAMETERS; CAUSE OF DEATH; COST UTILITY ANALYSIS; DESMOID TUMOR; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GASTROINTESTINAL DISEASE; HEALTH PROMOTION; HOME CARE; HUMAN; INTESTINE TRANSPLANTATION; LETTER; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATIENT CARE; PATIENT IDENTIFICATION; PATIENT REFERRAL; PRIORITY JOURNAL; RISK FACTOR; SHORT BOWEL SYNDROME; SURVIVAL RATE; THERAPY EFFECT; TREATMENT INDICATION;

EID: 83555179246     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2011.241075     Document Type: Letter

References (4)

1. Abu-Elmagd KM, Mazariegos C. Intestinal transplantation and the European implication: impact of experience and study. Gut 2012;61:166-7.
2. Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut 2011;60:17-25.
3. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525-32. (Pubitemid 30171891)
4. Abu-Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 2006;130(2 Suppl 1): S132-7. (Pubitemid 43208871)